Treace Medical Concepts (TMCI) Accounts Payables (2020 - 2026)

Treace Medical Concepts has reported Accounts Payables for 7 years, with the latest figure at $13.5 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables rose 2.37% year-over-year to $13.5 million; the trailing twelve-month figure through Mar 2026 stood at $13.5 million (up 2.37% YoY), and the FY2025 full-year result was $6.7 million, down 36.08% from the prior year.
• Accounts Payables for Q1 2026 stood at $13.5 million, up from $6.7 million in the prior quarter.
• The five-year high for Accounts Payables was $21.1 million in Q1 2024, with the low at $3.1 million in Q2 2022.
• Historically, Accounts Payables has averaged $11.5 million across 5 years, with a median of $10.5 million in 2024.
• Annual changes were most pronounced in 2024 — Accounts Payables jumped 316.65% — and 2025, when it slumped 37.48%.
• Treace Medical Concepts' Accounts Payables stood at $8.7 million in 2022, then soared by 36.54% to $11.8 million in 2023, then slipped by 11.09% to $10.5 million in 2024, then plunged by 36.08% to $6.7 million in 2025, then soared by 101.26% to $13.5 million in 2026.
• The last three Accounts Payables figures came in at $13.5 million (Q1 2026), $6.7 million (Q4 2025), and $16.1 million (Q3 2025), per Business Quant data.